Landiolol for managing atrial fibrillation in post-cardiac surgery

Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fellahi, Jean-Luc, Heringlake, Matthias, Knotzer, Johann, Fornier, William, Cazenave, Laure, Guarracino, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909770/
https://www.ncbi.nlm.nih.gov/pubmed/30188961
http://dx.doi.org/10.1093/eurheartj/sux038
Descripción
Sumario:Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of landiolol in that specific surgical setting.

Ejemplares similares